Arcus Biosciences: Peers

The FY2025 (Dec) proxy of Arcus Biosciences names 17 peer companies for pay. Among Arcus Biosciences and these peers, CEO pay was 3rd highest of 7 and total shareholder return was 2nd highest of 7.

3rd highest of 7in Arcus Biosciences and its pay peers, FY2025 (Dec) by CEO pay:

$4.2M$14.9M

2nd highest of 7in Arcus Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:

$14$108

Pay peer group, FY2025 (Dec) proxy

BridgeBio Pharma
ImmunityBio
Arvinas
Denali Therapeutics
Kura Oncology
Regenxbio
Alector, Inc.Not disclosedNot disclosed
Allogene Therapeutics, Inc.Not disclosedNot disclosed
Arrowhead Pharmaceutics, Inc.Not disclosedNot disclosed
Day One Biopharmaceuticals, Inc.Not disclosedNot disclosed
Editas Medicine, Inc.Not disclosedNot disclosed
Intella Therapeutics Inc.Not disclosedNot disclosed
Iovance BiotherapeuticsNot disclosedNot disclosed
Prothena Corporation PlcNot disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
XencorNot disclosedNot disclosed
17 companies

Changes by year

FY2025 (Dec) proxy

  • AddedAlector, Inc.pay peer group
  • AddedArvinaspay peer group
  • RemovedCytokineticspay peer group
  • RemovedMirati Therapeuticspay peer group

FY2024 (Dec) proxy

  • AddedBridgeBio Pharmapay peer group
  • AddedDay One Biopharmaceuticals, Inc.pay peer group
  • AddedImmunityBiopay peer group
  • RemovedApellis Pharmaceuticals, Inc.pay peer group
  • RemovedFate Therapeutics Inc.pay peer group
  • RemovedImmunoGen, Inc.pay peer group
  • RemovedRevance Therapeutics Inc.pay peer group

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.